LGVN Form 4: Lisa Locklear Acquires 11,766 Shares and 29,415 Warrants
Rhea-AI Filing Summary
Lisa Locklear, identified on the Form 4 as Chief Financial Officer and a director of Longeveron Inc. (LGVN), made a direct purchase on 08/11/2025 of 11,766 shares of Class A common stock. Each purchased share was accompanied by two and one-half Class A common warrants, for a total of 29,415 warrants, and the combined purchase price for each share plus accompanying warrants was $0.85. Following the reported transaction, Ms. Locklear directly beneficially owned 250,964 shares of Class A common stock.
The warrants are shown with an exercise/conversion price of $0.85 and an expiration date of 08/11/2027, and the reported holdings and transactions are recorded as direct ownership on the Form 4.
Positive
- Insider purchase recorded: 11,766 Class A shares acquired directly on 08/11/2025
- Accompanying warrants: 29,415 Class A warrants received (2.5 warrants per share) with exercise price $0.85
- Increased direct ownership to 250,964 Class A common shares following the transaction
Negative
- None.
Insights
TL;DR: CFO purchased common stock with bundled warrants at $0.85, raising direct holdings to 250,964 shares; transaction reported on Form 4.
The filing shows a direct purchase code (P) dated 08/11/2025 for 11,766 Class A shares bundled with two and one-half warrants per share (29,415 warrants total). The combined per-share purchase price, which also reflects the warrants, is reported as $0.85. Post-transaction direct common stock ownership is 250,964 shares. These are explicit, verifiable facts from the Form 4; the document does not disclose cash paid beyond the combined price, nor context on proportionality versus total outstanding shares.
TL;DR: Reported insider purchase filed under Section 16; ownership updated and warrants disclosed, with no other governance changes reported.
The Form 4 identifies Lisa Locklear as both an officer (Chief Financial Officer) and a director and records the transaction as direct beneficial ownership. The derivative instrument details are explicit: warrants exercisable beginning 08/11/2025, expiring 08/11/2027, with an exercise/conversion price of $0.85. The filing includes the standard Form 4 disclosures; it does not include amendments, sales, or changes to board composition.
FAQ
What did Longeveron insider Lisa Locklear report on Form 4 (LGVN)?
How many warrants did Lisa Locklear receive and what are their terms?
What is Lisa Locklear’s beneficial ownership after the transaction?
Was the transaction reported as direct or indirect ownership on the Form 4?
What purchase code is used for this Form 4 transaction?